<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><condition>Breast ,Gastrointestinal and gyanecological cancers</condition><condition>Malignant neoplasms of breast</condition><condition>Diseases of the genitourinary system</condition><condition>Malignant neoplasm of intestinal tract, part unspecified</condition><disease>Diseases Of The Genitourinary System</disease><disease>Breast ,gastrointestinal And Gyanecological Cancers</disease><disease>Malignant Neoplasm Of Intestinal Tract, Part Unspecified</disease><disease>Malignant Neoplasms Of Breast</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2578129</full_dataset_link><location>India</location><study_start_month>10</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>validation model to assess toxicities in elderly patients of BREAST ,GASTROINTESTINAL AND GYANEACOLOGICAL CANCERS</name><description>Primary outcome(s): To evaluate the linear relationship between Hurria toxicity prediction score and actual occurrence of grade 3-4 toxicity in the study cohort of elderly patientsTimepoint: 36 months</description><dates><creation>2016-10-15</creation></dates><accession>2578129</accession><cross_references><Clinical Trials Registry - India>CTRI-2016-10-007357</Clinical Trials Registry - India></cross_references></HashMap>